Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026)

Zoetis' (ZTS) quarterly Other Accumulated Expenses came in at $121.0 million in Q1 2026, down 84.33% year-on-year from $772.0 million in Q1 2025, and down 85.61% on a QoQ basis from $841.0 million in Q4 2025.

Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026) Analysis & Trends

Zoetis (ZTS) has 14 years of Other Accumulated Expenses data on file, last reported at $121.0 million in Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses fell 84.33% year-over-year to $121.0 million in Q1 2026; TTM through Mar 2026 was $121.0 million, a 84.33% decrease from a year earlier, with the FY2025 full-year figure at $841.0 million, up 572.8% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $121.0 million, down from $841.0 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for ZTS reached as high as $841.0 million in Q4 2025 and fell as low as $89.0 million in Q1 2024.
  • Historically, Other Accumulated Expenses has averaged $399.8 million across 5 years, with a median of $125.0 million in 2024.
  • Across the five-year window, Other Accumulated Expenses tumbled 87.3% in 2024 and soared 767.42% in 2025, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $97.0 million in 2022, then gained by 5.15% to $102.0 million in 2023, then increased by 22.55% to $125.0 million in 2024, then jumped by 572.8% to $841.0 million in 2025, then tumbled by 85.61% to $121.0 million in 2026.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $121.0 million in Q1 2026, $841.0 million in Q4 2025, and $99.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.88 Bn 87.01 Bn -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn
3 Zoetis 32.31 Bn 30.37 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn
8 Neurocrine Biosciences 17.92 Bn 16.61 Bn 800.70 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 121.00 Mn
Dec 31, 2025 841.00 Mn
Sep 30, 2025 99.00 Mn
Jun 30, 2025 770.00 Mn
Mar 31, 2025 772.00 Mn
Dec 31, 2024 125.00 Mn
Sep 30, 2024 115.00 Mn
Jun 30, 2024 704.00 Mn
Mar 31, 2024 89.00 Mn
Dec 31, 2023 102.00 Mn
Sep 30, 2023 97.00 Mn
Jun 30, 2023 689.00 Mn
Mar 31, 2023 701.00 Mn
Dec 31, 2022 97.00 Mn
Sep 30, 2022 679.00 Mn
Jun 30, 2022 696.00 Mn
Mar 31, 2022 99.00 Mn
Dec 31, 2021 67.00 Mn
Sep 30, 2021 618.00 Mn
Jun 30, 2021 646.00 Mn